Section Arrow
Quote
WVE.NASDAQ
- Wave Life Sciences Ltd
Quotes are at least 15-min delayed:2024/10/31 20:47 EDT
Last
 13.71
-0.61 (-4.26%)
Day High 
14.19 
Prev. Close
14.32 
1-M High
15.9199 
Volume 
1.57M 
Bid
13.51
Ask
13.71
Day Low
13.441 
Open
14.14 
1-M Low
7.85 
Market Cap 
2.12B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 14.79 
20-SMA 11.92 
50-SMA 8.55 
52-W High 15.9199 
52-W Low 3.5 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.57/-0.80
Enterprise Value
2.14B
Balance Sheet
Book Value Per Share
-0.02
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
113.31M
Operating Revenue Per Share
0.25
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ELABElevai Labs0.059-0.0339-36.49%-- 
AVTEAerovate Therapeutics2.46+0.27+12.33%-- 
ENSCEnsysce Biosciences0.5754-0.0629-9.85%-- 
TNXPTonix Pharmaceuticals Holding Corp.0.1445-0.0099-6.41%-- 
GLYCGlycoMimetics0.4069-0.0496-10.87%-- 
Quotes are at least 15-min delayed：2024/10/31 20:47 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.